Curium and RadioMedix Announce Exclusive Global Agreement for 64Cu-Dotatate Development
26 août 2018 21h00 HE
|
Curium
St. Louis and Houston, Aug. 26, 2018 (GLOBE NEWSWIRE) -- Curium and RadioMedix Inc. announce an exclusive agreement to develop and commercialize 64Cu-Dotatate, an investigational positron emission...